| scholarly article | Q13442814 |
| P50 | author | Mihaela Zavolan | Q15671899 |
| Erik van Nimwegen | Q16914877 | ||
| Sara B Angleman | Q47824904 | ||
| Alan S. Perelson | Q55719625 | ||
| Richard M Siegel | Q58335884 | ||
| P2093 | author name string | Michael J Lenardo | |
| Christina Speirs | |||
| Diane Bolton | |||
| Melody Duvall | |||
| P2860 | cites work | Pathogenesis of human immunodeficiency virus infection | Q24634681 |
| The mitochondriotoxic domain of Vpr determines HIV-1 virulence | Q24674929 | ||
| Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis | Q24675034 | ||
| Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity | Q24685633 | ||
| HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells | Q28208528 | ||
| The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway | Q28211664 | ||
| The global impact of HIV/AIDS | Q28213337 | ||
| HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease | Q28267375 | ||
| HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time | Q29547822 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene | Q29615351 | ||
| HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy | Q29616404 | ||
| Decay characteristics of HIV-1-infected compartments during combination therapy | Q29619375 | ||
| Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells | Q30789734 | ||
| The dynamics of CD4+ T-cell depletion in HIV disease | Q33942992 | ||
| Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein | Q33953195 | ||
| Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells | Q33957148 | ||
| Evidence for a cytopathogenicity determinant in HIV-1 Vpr. | Q34035915 | ||
| The human immunodeficiency virus: infectivity and mechanisms of pathogenesis | Q34049376 | ||
| The immunopathogenesis of human immunodeficiency virus infection | Q34060285 | ||
| Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. | Q34338445 | ||
| Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis | Q34338458 | ||
| Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis | Q34536238 | ||
| Mechanism of HIV-1 viral protein R-induced apoptosis | Q35120771 | ||
| Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. | Q35855811 | ||
| Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy | Q36376383 | ||
| Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells | Q36806944 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. | Q39880513 | ||
| Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors | Q41016329 | ||
| Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses. | Q41060852 | ||
| Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein | Q41097817 | ||
| Pathway of vesicular stomatitis virus entry leading to infection | Q43674816 | ||
| Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. | Q52040570 | ||
| CD4+ cell turnover | Q60074692 | ||
| T Cell Apoptosis Causes Peripheral T Cell Depletion in Mice Transgenic for the HIV-1 vpr Gene | Q62735899 | ||
| Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? | Q72768982 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 4025-4032 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture | |
| P478 | volume | 79 |
| Q36354421 | Diagnostic approaches for viruses and prions in stem cell banks |
| Q28469341 | Emergence of recombinant forms of HIV: dynamics and scaling |
| Q34120725 | Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naïve to Nevirapine by Using Stochastic Simulations and a Mathematical Model |
| Q33852032 | HIV dynamics with multiple infections of target cells |
| Q36152005 | Human genetic approaches to diseases of lymphocyte activation |
| Q28480578 | Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy |
| Q39390501 | Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model |
| Q36806548 | Quantifying T lymphocyte turnover |
| Q34480135 | The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest |
| Q28474857 | Timing the emergence of resistance to anti-HIV drugs with large genetic barriers |
Search more.